Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.

Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check36 days agoChange DetectedThe page has been updated to include new collaborators, specifically Merck Sharp & Dohme LLC and the Big Ten Cancer Research Consortium, and the study revision has been updated to v2.15.0. Additionally, the study title has been modified to reflect the focus on Clear Cell Renal Carcinoma.SummaryDifference48%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check51 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2.SummaryDifference0.0%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check101 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.